ashleyk said: "It's too bad that these FDA approved drugs are not fast tracked into some sort of trial to see how effective they could be in PD and AD. Many are years into these diseases and time is running out."

Okay, now I see where you are coming from.

I don't disagree with you. It seems to me that it would indeed be a good thing if some researcher took the initiative and sought funding for a trial of one or more of these drugs in PD and AD, similar to what is happening in the case of nilotinib.

As you say, time is running out for many PWPs and PWAs.